Repository corticotropin (Acthar Gel)

Peptide

Approvedregulatory verdict

Evidence outlook

Approved: Multiple Sclerosis, Psoriatic Arthritis, Epilepsy, Rheumatoid Arthritis, Systemic Lupus Erythematosus, Multiple Sclerosis Exacerbations, Dermatomyositis, Idiopathic Inflammatory Myopathies, Non-Infectious Uveitis, Lupus Nephritis

Regulatory approval supersedes design-level evidence grading; the trials behind approval are preserved below as the drug's evidence history.

track record: Weak signal

How the evidence outlook works ↗

All registered studies

Every ClinicalTrials.gov study of this drug's own program. Studies backing a featured trial above are marked Featured; the rest aren't individually graded. Filter by which indication a study was run for, then browse by phase. Studies where this drug served as another program's comparator, or is merely referenced, are listed separately below.

Phase 3 (5)
Multiple Sclerosis
Rheumatoid Arthritis
NCT03511625 · Attune Health Research, Inc.
2018-10-02 – 2024-12-03 · Rheumatoid Arthritis
What this study did
Other / comorbidity
NCT02282930 · Mayo Clinic
2015-03 – 2018-06-30 · Progressive IgA Nephropathy, Proteinuria
What this study did
NCT02132195 · Emory University
2014-05 – 2018-03 · Nephrotic Syndrome
What this study did
Phase 2/3 (5)
Multiple Sclerosis
Other / comorbidity
NCT06201897 · All India Institute of Medical Sciences
2024-03 – 2026-06 · West Syndrome
What this study did
NCT03068754 · Mallinckrodt
2017-06-22 – 2019-11-25 · Amyotrophic Lateral Sclerosis
What this study did
NCT02348905 · Albany Medical College
2015-03 – 2016-01 · Sarcoidosis, Cutaneous Sarcoidosis
What this study did
NCT02155803 · Albany Medical College
2015-02 – 2015-11 · Sarcoidosis, Hypercalcemia Due to Sarcoidosis
What this study did
Phase 2 (12)
Idiopathic Inflammatory Myopathies
NCT01906372 · Rohit Aggarwal, MD
2013-09 – 2016-05 · Dermatomyositis, Polymyositis
What this study did
Multiple Sclerosis
NCT01950234 · University of Minnesota
2014-04-17 – 2022-12-31 · Secondary Progressive Multiple Sclerosis, Primary Progressive Multiple Sclerosis, Progressive Relapsing Multiple Sclerosis
What this study did
NCT00986960 · University at Buffalo
2009-12 – 2010-12 · Multiple Sclerosis
What this study did
Rheumatoid Arthritis
NCT01984268 · Dartmouth-Hitchcock Medical Center
2014-06-23 – 2016-09-01 · Rheumatoid Arthritis
What this study did
Other / comorbidity
NCT07833163 · Peking University People's Hospital
2026-09 – 2029-09 · Behçet's Syndrome, Behçet's Syndrome (BS)
What this study did
NCT03465111 · Metropolitan Eye Research & Surgery Institute
2019-01-01 – 2024-12-08 · Scleritis
What this study did
NCT02574962 · Mamatha Pasnoor, MD
2015-08 – 2018-07 · Chronic Inflammatory Demyelinating Polyneuropathy
What this study did
NCT02113735 · Mallinckrodt
2014-08 – 2016-08 · Acute Respiratory Distress Syndrome
What this study did
NCT01601236 · Mallinckrodt
2012-05 – 2016-03 · Diabetic Nephropathy
What this study did
NCT01906658 · Mallinckrodt
2013-07 – 2014-12 · Amyotrophic Lateral Sclerosis
What this study did
NCT00694863 · Radboud University Medical Center
2008-07 – 2012-12 · Idiopathic Membranous Nephropathy
What this study did
Phase 1/2 (1)
Other / comorbidity
NCT01093157 · University Health Network, Toronto
2010-02 – 2013-02 · Glomerulonephritis
What this study did
Phase 1 (7)
Multiple Sclerosis
NCT01049451 · University of Southern California
2009-11 – 2013-07 · Multiple Sclerosis
What this study did
Other / comorbidity
NCT03905603 · University of Virginia
2019-10-08 – 2026-05-01 · Polycystic Ovary Syndrome
What this study did
NCT03727776 · Johns Hopkins University
2019-08-19 – 2023-07-07 · Proliferative Vitreoretinopathy
What this study did
NCT03709381 · Nationwide Children's Hospital
2017-10-01 – 2019-01-31 · Adrenal Insufficiency, Osteopenia, Osteoporosis, Steroid Suppression of ACTH Secretion
What this study did
NCT01987167 · Neuro-Ophthalmologic Associates, PC
2013-11 – 2016-12 · Optic Neuritis
What this study did
NCT02486744 · Youngstown State University
2015-03 – 2016-07 · End Stage Renal Disease
What this study did
NCT00805753 · Mayo Clinic
2009-01 – 2014-09 · Idiopathic Membranous Nephropathy
What this study did
Phase 4 (48)
Epilepsy
NCT02092883 · Wayne State University
2013-03 – 2017-07 · Infantile Spasms
What this study did
Idiopathic Inflammatory Myopathies
NCT02245841 · The Cleveland Clinic
2015-06-15 – 2021-07-14 · Dermatomyositis, Juvenile Dermatomyositis
What this study did
Multiple Sclerosis
NCT01838174 · University of Colorado, Denver
2013-05 – 2022-01-13 · Multiple Sclerosis
What this study did
NCT03021317 · University of Chicago
2016-12-20 – 2020-10-07 · Multiple Sclerosis
What this study did
NCT03126760 · Mallinckrodt ARD LLC
2017-05-22 – 2020-07-14 · Multiple Sclerosis, Relapsing-Remitting
What this study did
NCT02446886 · Weill Medical College of Cornell University
2016-06 – 2020-06 · Multiple Sclerosis
What this study did
NCT01888354 · The University of Texas Health Science Center, Houston
2013-04 – 2014-08 · Multiple Sclerosis (MS)
What this study did
Psoriatic Arthritis
NCT03419650 · IRIS Research and Development, LLC
2018-07-20 – 2021-08-25 · Psoriatic Arthritis
What this study did
NCT01939132 · Fiechtner, Justus J., M.D., P.C.
2013-07 – 2014-11 · Psoriatic Arthritis
What this study did
Rheumatoid Arthritis
NCT02541955 · Veena Ranganath, MD, MS
2017-07-20 – 2025-05-20 · Rheumatoid Arthritis (RA)
What this study did
NCT02919761 · Mallinckrodt
2016-11-07 – 2019-02-13 · Arthritis, Rheumatoid
What this study did
NCT03082573 · Iraj Sabahi Research Inc.
2017-03-03 – 2019-02 · Rheumatoid Arthritis
What this study did
NCT01948388 · Gaylis, Norman B., M.D.
2013-09 – 2016-09 · Rheumatoid Arthritis
What this study did
NCT01966718 · Arthritis Treatment Center, Maryland
2013-10 – 2015-10 · Rheumatoid Arthritis
What this study did
Systemic Lupus Erythematosus
NCT02226341 · Columbia University
2014-10 – 2024-01-03 · Lupus Nephritis
What this study did
NCT02953821 · Mallinckrodt
2016-12-16 – 2019-10-25 · Lupus Erythematosus, Systemic
What this study did
NCT02779153 · NYU Langone Health
2016-10 – 2019-05-22 · Systemic Lupus Erythematosus (SLE), Repository Corticotropin Injection
What this study did
NCT01926054 · Ohio State University
2013-07 – 2018-02-28 · SLE Glomerulonephritis Syndrome, WHO Class V
What this study did
NCT01753401 · Mallinckrodt
2013-01 – 2015-10 · Systemic Lupus Erythematosus (SLE)
What this study did
NCT01769937 · Fiechtner, Justus J., M.D., P.C.
2012-10 – 2013-04 · Lupus Erythematosus Systemic Exacerbation
What this study did
Other / comorbidity
NCT06964269 · Toyos Clinic
2025-02-11 – 2028-02-28 · Autoimmune Diseases, Dry Eye, Neurotrophic Keratitis
What this study did
NCT02523092 · University of California, San Francisco
2022-11-03 – 2025-01-31 · Sarcoidosis
What this study did
NCT05546047 · NephroNet, Inc.
2019-03-14 – 2024-10-27 · Fibrillary Glomerulonephritis
What this study did
NCT04080076 · NephroNet, Inc.
2019-01-12 – 2024-09-06 · Renal Disease
What this study did
NCT05071781 · Universitaire Ziekenhuizen KU Leuven
2021-05-21 – 2022-12-19 · GI Motility Disorder
What this study did
NCT03320070 · Mallinckrodt
2018-02-21 – 2021-11-15 · Sarcoidosis, Pulmonary
What this study did
NCT02399462 · University of North Carolina, Chapel Hill
2021-03 – 2021-07-31 · FSGS, Renal Transplantation, Kidney Transplantation
What this study did
NCT03408405 · Rhode Island Hospital
2018-06 – 2021-07 · Steroid-Resistant Nephrotic Syndrome
What this study did
NCT02546492 · University of Maryland, Baltimore
2016-08 – 2021-05-27 · Transplant Glomerulopathy
What this study did
NCT03025828 · Icahn School of Medicine at Mount Sinai
2018-03-19 – 2020-12-16 · Membranous Nephropathy
What this study did
NCT04169061 · Mallinckrodt
2019-11-13 – 2020-12-07 · Keratitis
What this study did
NCT02920710 · The Cleveland Clinic
2019-02-01 – 2020-11-02 · Sarcoidosis
What this study did
NCT02298491 · University of Maryland, Baltimore
2016-05 – 2020-11 · CNS Sarcoidosis
What this study did
NCT02633046 · Mallinckrodt ARD LLC
2016-10-10 – 2020-08-27 · Idiopathic Focal Segmental Glomerulosclerosis
What this study did
NCT03066869 · Ocular Immunology and Uveitis Foundation
2017-03-22 – 2020-08 · Uveitis, Posterior, Vasculitis Retinal
What this study did
NCT03656692 · Mallinckrodt
2018-10-05 – 2020-07-14 · Uveitis, Posterior, Uveitis, Intermediate, Panuveitis
What this study did
NCT03287635 · Toyos Clinic
2018-07-01 – 2020-03-04 · Dry Eye Disease
What this study did
NCT02382523 · Baylor College of Medicine
2015-02 – 2020-01 · IgA Nephropathy, Proteinuria
What this study did
NCT03398018 · University of Alabama at Birmingham
2018-11-01 – 2018-11-01 · Keratoconjunctivitis Sicca
What this study did
NCT02188017 · University of Cincinnati
2014-06 – 2017-09 · Sarcoidosis, Pulmonary Sarcoidosis
What this study did
NCT01386554 · Mallinckrodt
2011-08 – 2017-05-05 · Proteinuria, Idiopathic Membranous Nephropathy
What this study did
NCT02769702 · Washington University School of Medicine
2016-06 – 2017-01-06 · Uveitis
What this study did
NCT02413944 · Bnai Zion Medical Center
2015-04 – 2016-10 · Healthy
What this study did
NCT02057523 · University of Illinois at Chicago
2014-09 – 2015-09 · Proteinuria, Transplant Glomerulopathy
What this study did
NCT01155141 · Stanford University
2009-09 – 2014-01 · Kidney Diseases
What this study did
NCT01129284 · Columbia University
2009-12 – 2011-09 · Treatment Resistant Nephrotic Syndrome
What this study did
NCT01028287 · Southeast Renal Research Institute
2009-05 – 2011-07 · Diabetic Nephropathy, Nephrotic Syndrome
What this study did
NCT01021540 · Arizona Kidney Disease and Hypertension Center
2009-12 – 2010-10 · Nephrotic Syndromes
What this study did
Early phase / not applicable (19)
Multiple Sclerosis
NCT01900093 · Aaron Miller
2013-07 – 2018-03 · Multiple Sclerosis
What this study did
NCT02258217 · OhioHealth
2014-06 – 2016-12 · Relapsing Remitting Multiple Sclerosis
What this study did
NCT01906684 · Tanner Foundation for Multiple Sclerosis
2013-08 – 2015-01 · Multiple Sclerosis
What this study did
Rheumatoid Arthritis
NCT02030028 · Dana Ascherman
2014-11 – 2022-06-30 · Rheumatoid Arthritis
What this study did
NCT02434757 · Ronald J. Rapoport, MD
2014-02 – 2015-11 · Rheumatoid Arthritis
What this study did
Other / comorbidity
NCT04461535 · Chongqing Medical University
2020-07-08 – 2023-02-20 · Primary Aldosteronism
What this study did
NCT02725177 · The Cleveland Clinic
2016-07 – 2022-03 · Ocular Sarcoidosis, Panuveitis, Anterior Uveitis
What this study did
NCT01367964 · Ann & Robert H Lurie Children's Hospital of Chicago
2011-07 – 2020-05-05 · West Syndrome
What this study did
NCT04306653 · University of Patras
2018-01-05 – 2020-05 · Gout Attack
What this study did
NCT02972346 · Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
2016-11 – 2019-06 · Proteinuria
What this study did
NCT02006849 · Wake Forest University Health Sciences
2014-01 – 2019-01 · Kidney Disease
What this study did
NCT01373372 · Children's Mercy Hospital Kansas City
2016-12 – 2017-03 · Functional Dyspepsia
What this study did
NCT02501486 · Radboud University Medical Center
2015-07 – 2017-02 · Adrenal Insufficiency
What this study did
NCT03655509 · Rennes University Hospital
2015-08-22 – 2016-12-31 · Subarachnoid Hemorrhage
What this study did
NCT02368379 · Nationwide Children's Hospital
2014-03 – 2016-08 · Prader Willi Syndrome, Adrenal Insufficiency
What this study did
NCT01428336 · The Cleveland Clinic
2011-09 – 2015-01 · Adrenal Insufficiency
What this study did
NCT00666068 · Max-Planck-Institute of Psychiatry
2008-02 – 2008-12 · Hypopituitarism
What this study did
NCT00552487 · University of Wuerzburg
2005-10 – 2006-07 · Hashimoto Disease, Adrenal Insufficiency
What this study did
NCT00005890 · National Center for Research Resources (NCRR)
started 1996-03 · Septic Shock
What this study did
Used as active comparator (1)

Other programs' studies in which this drug was the registered active-comparator arm: a marker of standard-of-care status, not evidence of this drug's own progression.

Phase 2/3 (1)
Epilepsy
NCT05279118 · All India Institute of Medical Sciences
2022-04-18 – 2024-07-28 · Ketogenic Diet, West Syndrome, Infantile Spasm, ACTH
What this study did
Appears in other studies (1)

Studies that reference this drug without giving it an intervention arm of its own: other formulations' programs, background therapy, or registry-search bleed.

Phase 2 (1)
Other / comorbidity
NCT02931175 · Quan Dong Nguyen
2017-11-10 – 2021-10-28 · Uveitis
What this study did

Competitive landscape

This drug's own stage for Dermatomyositis: Approved. Competitors below are sorted furthest-along first.

DrugStageModalityMechanismEvidence signalReported efficacygraded featured trials
Repository Corticotropin (Acthar Gel): this drugApprovedPeptideMelanocortin receptors (primarily MC2R on the adrenal cortex), Melanocortin 2 receptor (MC2R) (agonist)not yet gradedNo reviewed efficacy summary in this indication
Brepocitinib (Lisraya)ApprovedSmall moleculeTYK2/JAK1not yet gradedNo reviewed efficacy summary in this indication
PF-06823859Phase 3Monoclonal antibodyInterferon beta (IFN-beta)not yet gradedNo reviewed efficacy summary in this indication
Descartes-08Phase 1/2Cell therapyBCMA (B-cell maturation antigen)not yet gradedNo reviewed efficacy summary in this indication
CadefrecitinibDiscontinuedSmall moleculeTYK2not yet gradedNo reviewed efficacy summary in this indication

Upcoming events

(2 total)

Estimated primary-completion dates from ClinicalTrials.gov. These are registry estimates, never confirmed readout dates; they can move as trials progress.

Follow Repository corticotropin (Acthar Gel) to get an email as a readout nears, when a date moves, or when a study changes status. Needs a free account.

Add these readouts to your calendar: Apple or Outlook · Google Calendar · .ics link. The calendar updates when a registry date moves.

2027 (1)
September 2027 (1)
Phase 2Behçet's Syndrome, Behçet's Syndrome (BS)Not yet recruiting
Est. primary completion 2027-09 · NCT07833163 · CT.gov ↗
What to watch
2028 (1)
February 2028 (1)
Phase 4Autoimmune Diseases, Dry Eye, Neurotrophic KeratitisRecruiting
Est. primary completion 2028-02-28 · NCT06964269 · CT.gov ↗
What to watch

See the full readout calendar ↗